SAN FRANCISCO — FedEx Corp., the latest company accused in a federal probe involving illegal online pharmacies, says it will fight the charges that it knowingly shipped drugs to people who lack valid prescriptions.
The company says it would have to invade the privacy of customers to stop such deliveries.
UPS Inc. paid $40 million last year to resolve similar allegations and vowed to overhaul its procedures and work with investigators to detect suspicious activity.
The contrasting responses to the decade-long federal probe of the prescription drug black market underscore the difficulty shippers have in determining how far to go to ferret out illicit online pharmacies among their customers and to alert the government.
Wall Street analysts, legal experts, anti-drug crusaders and the companies themselves are split on the issue.
FedEx could face $1.6 billion in penalties after its July 17 indictment on charges that it conspired with illegal online pharmacies to deliver prescription drugs to customers it knew lacked valid prescriptions.
The federal investigation of the two shipping giants stems from a blitz against online pharmacies that was launched in 2005. Since then, dozens of arrests have been made, thousands of websites shuttered and tens of millions of dollars and pills seized worldwide as investigators broadened the probe beyond the operators.
Google Inc. in 2011 agreed to pay $500 million to settle allegations by the U.S. Department of Justice that it profited from ads purchased by online pharmacies that the search giant knew was improperly selling prescription drugs.
Many online pharmacies fill orders without following proper prescription protocols, often requiring a customer to simply fill out an online form that is reviewed remotely by a physician.
“The advent of Internet pharmacies allowed the cheap and easy distribution of massive amounts of illegal prescription drugs to every corner of the United States, while allowing perpetrators to conceal their identities through the anonymity the Internet provides,” said San Francisco-based U.S. Attorney Melinda Haag.
